Introduction
Interleukin-4 (IL-4) is a pleiotropic cytokine exerting various effects on different cell types [1] . Together with IL-13 it is the key cytokine in atopic diseases, e.g. allergic asthma. STAT6 is a transcription factor activated selectively by IL-4 and IL-13, which is the subject of ongoing research. The generation of STAT6 gene-targeted mice allowed to specifically analyze the role of this transcription factor [2] [3] [4] . Cells of STAT6 gene-targeted mice fail to upregulate IL-4-induced genes such as MHC II, CD23 or the IL-4R ␣ chain upon IL-4 stimulation. Additionally, STAT6 KO mice cannot mount an efficient T helper 2 cell (Th2) immune response and class switching of B cells towards IgE production is completely abrogated. As a result of these defects, mice show reduced peribronchial inflammation and airway hyperresponsiveness in models of allergic asthma [5, 6] . The exact molecular mechanisms underlying these observations still remain incompletely understood.
To further address the role of STAT6 in IL-4-dominated immune responses, we included STAT6+/-mice as a control group in experiments with STAT6 tm1Gru genetargeted mice and wild-type mice. Surprisingly, STAT6+/-mice displayed a phenotype similar to STAT6-/-mice for some (IgE expression, antiparasitic immune response), but not all (enhanced expression of CD23 and MHC class II molecules on IL-4-stimulated B cells) IL-4-mediated functions analyzed. This finding argues for hitherto unknown distinct thresholds of activated STAT6 molecules for different IL-4-mediated functions.
Material and Methods
Animals BALB/c mice and mice heterozygous or deficient for STAT6 tm1Gru [2] were bred in our animal facility under specific pathogen-free conditions. Female mice between 6-8 weeks of age were used for the experiments according to the guidelines for animal welfare and legal requirements.
In vitro Class Switching
Single cell suspensions from spleens were enriched for B cells by depletion of cells positive for CD3, CD11b, Gr-1 and NK DX-5 using the magnetic labeling and separation protocol (BD Biosciences, Heidelberg, Germany) according to the manufacturer's recommendation. For class switching of splenic B cells towards IgE production, 1 ! 10 6 cells per well (24-well plate, culture volume 1 ml) were cultured either with medium alone or in the presence of ␣ -CD40 (FGK) antibody with or without 20 ng/ml recombinant IL-4 (Strathmann, Hamburg, Germany). Supernatants were collected on days 3, 5, 7 and 9 for IgE ELISA. On day 2 and 4 total RNA was isolated (RNeasy mini kit, Qiagen) from stimulated cells ( ␣ -CD40 + IL-4), and after reverse transcription with oligo-dT primers (SuperScript II RNase, Invitrogen) samples were analyzed for the presence of switch transcripts (germ line transcript: IeF and CeR, 392 bp; postswitch transcript: ImF and CeR, 285 bp; IeF: 5 -TGGGATCAGATCTTTGAG-3 , CeR: 5 -CCAGGGTCATGGAAGCAGTG-3 , ImF: 5 -CTCTGGCC C-TGCTTATTGTTG-3 ; PCR conditions: 37 cycles, annealing: 45 s, 65 ° C, elongation: 45 s, 72 ° C). Cells were analyzed by FACS analysis on day 4 for surface molecules CD23 and MHC II with antibodies from Pharmingen (BD Biosciences).
In vivo Class Switching
Mice on a susceptible BALB/c background were infected subcutaneously with 2 ! 10 6 promastigotes ( Leishmania major strain MHOM/IL/81/FEBNI) in the right hind footpad. Footpad swelling was monitored over time. On day 32 mice were sacrificed and sera were collected for ELISAs.
ELISAs
Sandwich ELISAs for total IgE and Leishmania -specific IgG1 and IgG2a were performed using the following antibodies: capture IgE: clone R35-72, 2 g/ml (Pharmingen); biotinylated IgE for detection: clone R35-118, 2 g/ml (Pharmingen); capture Leishmania -specific antibodies: preparation of total antigen (1 ! 10 9 Leishmania /ml, repeated freeze-thaw cycles, dilution 1: 200); biotinylated IgG1 for detection: clone G1-6.4, diluted 1: 1,000 (Pharmingen), and biotinylated IgG2a for detection: clone R19-15, diluted 1: 1,000 (Pharmingen). Biotinylated detection antibodies were coupled to HRP with the StrepAB-Complex (Dako Cytomation), and TMB (Sigma) was added as substrate.
Western Blot
Whole cell lysates of spleens from BALB/c wild-type, STAT6 heterozygous and STAT6-deficient mice were prepared in RIPA lysis buffer (150 m M NaCl, 1.0% Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 m M Tris, pH 8.0). 40 g of total protein per sample were applied to a polyacrylamide gel, and after blotting proteins were detected with specific antibodies: M-20 (1 g/ ml, Santa Cruz), M-200 (1 g/ml, Santa Cruz) or anti-actin A2066 (1: 250; Sigma). The secondary antibody (donkey-anti-rabbit-POX from Dianova) was diluted 1: 10,000 and blots were developed with the ECL Plus Western Blotting Detection System from Amersham. Quantification was performed with the AIDA software v4.03.031 (Raytest Isotopenmessgeräte, Straubenhardt, Ger many).
Statistics
Data were analyzed with either two-tailed t test or one-way ANOVA using GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, Calif., USA; www.graphpad.com).
Results and Discussion
In the present study we investigated IL-4-induced effects in STAT6+/-mice (Stat6 tm1Gru ) in comparison to wild-type and STAT6-deficient animals. Splenic B cells were isolated and stimulated in vitro with ␣ -CD40 + IL-4. Upregulation of the activation markers MHC II and the low affinity IgE receptor CD23 on stimulated B cells was assessed by FACS analysis. Mean fluorescence intensities ( 8 SD of at least three independent experiments) for MHC II expression were 547 8 129 compared to 1,646 8 189 for STAT6+/+ samples, 619 8 93 compared to 1,776 8 87 for STAT6+/-samples and 558 8 48 compared to 548 8 56 for STAT6-/-samples, comparing ␣ -CD40 stimulation with ␣ -CD40 + IL-4 stimulation. Mean fluorescence intensities for CD23 expression were 88 8 7 compared to 161 8 8 for STAT6+/+ samples, 77 8 16 compared to 116 8 20 for STAT6+/-samples and 77 8 16 compared to 85 8 8 for STAT6-/-samples, comparing ␣ -CD40 stimulation with ␣ -CD40 + IL-4 stimulation. So cells from STAT6+/-mice did upregulate MHCII expression to a similar extent as and CD23 expression to only a slightly reduced extent compared to cells from STAT6+/+ mice, whereas cells from STAT6-/-mice showed no upregulation of these molecules, as already described for the latter molecule [2] ( fig. 1 a) .
Class switching of stimulated B cells towards IgE production is preceded by the generation of a sterile germline transcript originating from the I promoter [7] . After class switch recombination, a postswitch transcript directed by the I promoter is detectable [8] . Both the germ line transcript generated from the original configuration of the Ig heavy chain locus as well as the postswitch transcript generated from the Ig heavy chain locus after class switch recombination were detectable in cDNA samples from IL-4-stimulated BALB/c STAT6+/+ B cells after 2 or 4 days, respectively. In contrast, these transcripts were strongly reduced in samples from STAT6+/-B cells. Most probably this residual transcriptional activity is due to ␣ -CD40 stimulation, as it does not exceed the level of transcription observed in STAT6-deficient mice ( fig. 1 b) [9] . Consistent with this observation, barely any IgE was detectable in supernatants of ␣ -CD40 + IL-4-stimulated B cells in STAT6+/-and STAT6-/-samples ( fig. 1 c) , reflecting the inability of STAT6+/-B cells to undergo IgE class switching upon IL-4 stimulation.
To confirm these in vitro data in an in vivo setting, we infected mice on a susceptible BALB/c background subcutaneously with the intracellular parasite L. major , an infection known to result in a Th2 cell-dominated immune response with high serum levels of IgE [10, 11] . Sera collected on day 32 postinfection exhibited high levels of IgE in STAT6+/+ mice ( 1 15 g/ml), whereas equally low levels ( ! 300 ng/ml) were detected in sera of STAT6+/-and STAT6-/-mice ( fig. 2 a) . This finding confirmed the inability of STAT6+/-mice to mount a pronounced IgE response in an in vivo setting. Additionally, STAT6+/-BALB/c mice were able to control infection with L. major ( fig. 2 b) , reflecting their inability to mount an IL-4-driven Th2-dominated immune response, which is responsible for the fatal outcome of this infection. To further substantiate this observation, we determined titers of Leishmania -specific IgG1 and IgG2a antibodies, being characteristic for a Th2-or a Th1-dominated immune response, respectively. A high ratio of IgG1 versus IgG2a titers is indicative of a Th2-biased immune response. STAT6+/+ mice exhibited a significantly higher IgG1/IgG2a ratio than both STAT6+/-and STAT6-/-mice, again arguing for an inefficient generation of a Th2-dominated immune response in STAT6+/-mice ( fig. 2 c) . STAT6 tm1Gru KO mice were generated by replacing exons encoding amino acids 505-584 with a neomycin resistance cassette, thereby deleting the genomic region coding for parts of the SH2 domain required for dimerization and functionality [2] . As we observed such marked phenotypes in heterozygous mice, we investigated whether a mutant STAT6 protein might be expressed from the targeted locus, possibly acting as a dominant negative protein and thereby abrogating STAT6 functionality in the heterozygous configuration. To further investigate the presence of such a truncated STAT6 protein, we analyzed cell lysates from mice either STAT6+/+, STAT6+/-or STAT6-/-in Western blot experiments using two different STAT6 antibodies directed against different domains of the protein. An antibody directed Mice on a susceptible BALB/c background, either wild type (+/+), STAT6 heterozygous (+/-) or STAT6 deficient (-/-), were infected with 2 ! 10 6 L. major promastigotes by subcutaneous injection into the right hind footpad. a Mice were bled on day 32 after infection and sera were analyzed by ELISA for IgE. p ! 0.001 wild type vs. heterozygous. b Footpad swelling was monitored over time. The thickness of the infected footpad vs. the uninfected footpad (ratio) is a measure for the severity of infection and inflammation. c Sera collected from infected mice on day 32 after infection were analyzed by ELISA for Leishmania -specific IgG1 and IgG2a antibodies. The ratio of IgG1 vs. IgG2a titers is depicted, being indicative of a Th2-dominated immune response. p ! 0.006 wild type vs. heterozygous. Data are expressed as mean 8 SEM (n = 6).
against the C terminus of STAT6 (M20) detected the protein in STAT6+/+ and STAT6+/-samples, whereas in STAT6 KO mice no protein was detectable ( fig. 3 a) . The relative amounts of STAT6 protein (normalized to actin) were estimated to be 56.0% and not detectable ( ! 1.5%) of the protein amount detectable in the STAT6+/+ configuration for STAT6+/-and STAT6-/-samples, respectively. This observation indicates that reduced STAT6 levels might be responsible for the phenotype observed in STAT6+/-mice. The second antibody raised against amino acids 280-480 (M200), a region upstream of the STAT6 gene disruption, also detected the wild-type protein of approximately 119 kDa, but failed to detect any truncated protein with a theoretical size of 54 kDa in STAT6+/-or STAT6-/-samples ( fig. 3 b) . As no evidence for a truncated version of STAT6 was obtained from these experiments, we consider it unlikely that such a molecule might be responsible for the observed phenotype of STAT6+/-mice. However, in humans, a naturally occurring STAT6 splice variant has been described that lacks 33 amino acids in the SH2 domain of STAT6 and that functions as a dominant negative species [12] . The gene-targeted STAT6 tm1Gru locus lacks exons encoding amino acids 505-584 of STAT6, which corresponds to 80 amino acids including those from the human dominant negative splice variant. Therefore, a truncated protein being present in the heterozygous configuration might theoretically be responsible for the observed deficiencies in STAT6+/-mice, but should have been detected by the STAT6-specific M200 antibody. Irrespective of these considerations, different IL-4-induced STAT6-dependent functions obviously display distinct STAT6 dosage requirements. Whether this is due to either a complex situation involving so far undetectable dominant negative STAT6 molecules, or -more likely -to a simple reduction of STAT6 concentrations in the heterozygous configuration is subject of ongoing experiments in our laboratory. Western blot analysis of whole cell lysates of wild-type (+/+), STAT6 heterozygous (+/-) and STAT6-deficient (-/-) mice. Proteins were extracted from single cell suspensions of splenocytes with RIPA lysis buffer. 40 g of total protein were separated on a polyacrylamide gel, and after Western blotting, blots were probed with STAT6-specific antibodies either recognizing the C-terminus of STAT6 (M20) ( a ) or amino acids 280-480 of the STAT6 protein (M200) ( b ). Blots were reprobed with an actin-specific antibody as a loading control.
